Company / Assets per Share
MADRIGAL PHARMACEUTICALS, INC. Assets per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$57.24
FY2025
5-year range
$17.63 / $57.24
FY2021-FY2025
Trend
+9.2%
vs FY2024
Sector context
#18 of 210
Health Care
What the data says
Among 210 Health Care companies, MADRIGAL PHARMACEUTICALS, INC. is in the top 9% for assets per share. Assets per Share has increased for 4 consecutive years, from $17.63 in FY2021 to $57.24 in FY2025.
Based on SEC 10-K filings.
57.24 in FY2025 with a 5-year CAGR of +25.2%. Top quartile in the Health Care sector.
Improved from $35.38 to $57.24 over the past 2 years.
Health Care sector context is included.
Assets per Share over time
Growth rates
- 3-Year CAGR
- +39.3%
- 5-Year CAGR
- +25.2%
- 10-Year CAGR
- -
Sector benchmark
Top 9% in Health CareTop 9% of 210This company $57.24 Sector average $353.15
▼
-83.8% below sector average
Key checks
Key Insights
- MADRIGAL PHARMACEUTICALS, INC.'s assets per share has grown for 4 consecutive years.
- In FY2025, assets per share increased 9.2% year-over-year.
- Ranks #18 out of 210 companies in the Health Care sector.
- Lowest assets per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -0.47 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $57.24 | +9.2% |
| FY2024 | $52.44 | +48.2% |
| FY2023 | $35.38 | +67.2% |
| FY2022 | $21.16 | +20.0% |
| FY2021 | $17.63 | -5.2% |
| FY2020 | $18.60 | -35.2% |
| FY2019 | $28.71 | -12.5% |
| FY2018 | $32.81 | +108.9% |
| FY2017 | $15.71 | +98.4% |
| FY2016 | $7.92 | +570.3% |
As of FY2025 · SEC 10-K · Updated Mar 29, 2026